Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weibond Technology is a specialized medical technology company focused on the automation of intravenous (IV) medication preparation. The company develops and manufactures sophisticated robotic systems designed to compound hazardous drugs, including chemotherapy and antibiotics, within a sterile environment. These robotic solutions aim to eliminate human error, ensure dosage precision, and protect healthcare professionals from occupational exposure to toxic substances. Weibond's technology integrates seamlessly with hospital information systems to streamline pharmacy workflows and enhance patient safety. Headquartered in Shenzhen, the company has established itself as a leader in the Chinese pharmacy automation market and is expanding its global footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weibond Technology.